propranolol - Generic mfg.
Journavx (suzetrigine) - Vertex
Reversing central maladaptive plasticity with vagus nerve stimulation to treat chronic neuropathic pain (Neuroscience 2026) - Sep 27, 2026 - Abstract #NANO13.10; Pres time: Nov 15, 2026; 03:15 PM - 03:30 PM; Location: WCC Rm 143; "So do rats with suzetrigine (peripheral nociceptor inhibitor) and Moderate VNS, implicating the overactivation of the noradrenergic system resulting from nociception. Propranolol however was not effective at increasing withdrawal threshold, suggesting that noradrenergic modulation during VNS alone is not sufficient for driving improved somatosensation. This study explored the neurological mechanisms underpinning pain and VNS-driven plasticity, and lays the groundwork for developing a fundamentally novel, promising approach toward a long-lasting rehabilitation of post-injury chronic pain." 
CNS Disorders • Neuralgia • Pain
https://www.abstractsonline.com/pp8/#!/21503/presentation/33691
 
C. L. NEIFERT1,2; T. T. DANAPHONGSE2; M. P. KILGARD3,2; S. A. HAYS1,2
 
Sep 27, 2026
 
Prev Next